IP Library Granted Patent US 7,671,192
Granted Patent B2
US 7,671,192 · App. 11/750,295 · Granted Mar 2, 2010

Process for preparing an A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,671,192
App. No.
11/750,295
Granted
Mar 2, 2010
Kind
B2
Abstract

Synthesis methods suitable for large scale manufacture of the A 2A -adenosine receptor agonist (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide and precursors thereof.

Claims (21)

1. A method of synthesizing (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide

by contacting a compound of the formula (4):

and wherein the reaction is with aqueous methylamine at a temperature of approximately 2.5-7.5° C. conducted in a sealed pressure reactor.

2. The method of claim 1 , further comprising wherein the product is isolated by

(a) degassing under vacuum at not more than 35° C. to remove excess methylamine,

(b) releasing the vacuum and cooling to 0-5° C. for approximately 15-minutes to an hour,

(c) filtering the slurry thus formed,

(d) washing the contents of the filter with water followed by ethanol, and

(e) drying the solid that remains under vacuum at a temperature that does not exceed 40° C.

3. The method of claim 2 further comprising wherein the (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide end product is further purified by

(i) dissolving the dried solid from step (e) of claim 2 in a solvent,

(ii) filtering any solid impurities from the solution,

(iii) rinsing with additional solvent,

(iv) adding solution to purified water that is maintained at approximately 78-88° thereby forming a slurry,

(v) stirring the slurry,

(vi) cooling the slurry,

(vii) filtering,

(viii) washing the contents of the filter with water followed by ethanol, and

(ix) drying the solid that remains under vacuum at a temperature that does not exceed 40° C.

4. The method of claim 3 , further comprising wherein the solvent of steps (i) and (iii) is dimethylsulfoxide.

5. The method of claim 4 , further comprising wherein the residual water content in the final product is not more than 5.5% and the residual ethanol is not more that 2000 ppm.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2013
From: LEMONS, TRAVIS; SEEMAYER, ROBERT
To: GILEAD SCIENCES, INC.
Reel/Frame 029716/0839 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2011
From: GILEAD PALO ALTO, INC.
To: GILEAD SCIENCES, INC.
Reel/Frame 026424/0925 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2011
From: ZABLOCKI, JEFF; ELZEIN, ELFATIH
To: GILEAD SCIENCES, INC.
Reel/Frame 025929/0602 →
MERGER Recorded Jan 13, 2010
From: APEX MERGER SUB, INC.; CV THERAPEUTICS, INC.
To: GILEAD PALO ALTO, INC.
Reel/Frame 023779/0821 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2010
From: TPG-AXON ROYALTY TRUST
To: TPG-AXON LEX SUB-TRUST
Reel/Frame 023731/0916 →
MERGER Recorded Oct 6, 2009
From: GILEAD PALO ALTO, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 023330/0648 →
SECURITY AGREEMENT Recorded Apr 16, 2008
From: CV THERAPEUTICS, INC.
To: TPG-AXON ROYALTY TRUST
Reel/Frame 020808/0823 →